These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 1242309)

  • 21. Potential anti-tumour 2,5-bis (1-aziridinyl)-1,4-benzoquinones: relationship between cytotoxicity against DNA-repair deficient E. coli, inactivation of bacteriophage M13mp19, and in vitro and in vivo anti-tumour activity.
    Lusthof KJ; Groothuis-Pielage IL; Decuyper J; de Mol NJ; Janssen LH; Verboom W; Reinhoudt DN
    Anticancer Drug Des; 1988 Dec; 3(3):147-55. PubMed ID: 3061386
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antitumor activities of newly synthesized 5-carbamoyl-1 H-imidazol-4yl 1-adamantanecarboxylate and 5-carbamoyl-1H-imidazol-4yl piperonylate.
    Yoshida N; Kiyohara T; Fukui M; Atsumi T; Ogino S; Inaba M; Tsukagoshi S; Sakurai Y
    Cancer Res; 1980 Oct; 40(10):3810-4. PubMed ID: 7438064
    [TBL] [Abstract][Full Text] [Related]  

  • 23. 1,2-Bis(methylsulfonyl)-1-(2-chloroethyl)-2-(methylamino)carbonylhydrazine (101M): a novel sulfonylhydrazine prodrug with broad-spectrum antineoplastic activity.
    Finch RA; Shyam K; Penketh PG; Sartorelli AC
    Cancer Res; 2001 Apr; 61(7):3033-8. PubMed ID: 11306484
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cytostatic effect of homo-aza-steroidal esters in vivo and in vitro. Structure-activity relationships.
    Catsoulacos P; Camoutsis C; Papageorgiou A; Adamiak-Margariti E
    Anticancer Res; 1992; 12(5):1617-20. PubMed ID: 1444229
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Free oxygen radiacals and kidney diseases--part I].
    Sakac V; Sakac M
    Med Pregl; 2000; 53(9-10):463-74. PubMed ID: 11320727
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Isothiazolopyrimidines--new group of anticancer agents. I.
    Machoń Z; Wieczorek J; Mordarski M
    Arch Immunol Ther Exp (Warsz); 1987; 35(5):599-607. PubMed ID: 3455649
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibition of proliferation of Ehrlich ascites carcinoma cells in vitro and in vivo by halogeno analogues of long chain acyl- and alkylglycerols.
    Langen P; Brachwitz H; Schildt J
    Acta Biol Med Ger; 1979; 38(7):965-74. PubMed ID: 543374
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antineoplastic activity of new linear hydrazine derivatives.
    Fiszer-Maliszewska L; Peczyńska-Czoch W; Wieczorek J; Mordarski M; Balicki R; Nantka-Namirski P
    Arch Immunol Ther Exp (Warsz); 1987; 35(2):225-35. PubMed ID: 3447537
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of bisphosphonates on the growth of Entamoeba histolytica and Plasmodium species in vitro and in vivo.
    Ghosh S; Chan JM; Lea CR; Meints GA; Lewis JC; Tovian ZS; Flessner RM; Loftus TC; Bruchhaus I; Kendrick H; Croft SL; Kemp RG; Kobayashi S; Nozaki T; Oldfield E
    J Med Chem; 2004 Jan; 47(1):175-87. PubMed ID: 14695831
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Chemotherapeutically active nitro compounds. 2nd communication: Nitrodiphenyl sulfones (author's transl)].
    Winkelmann E; Raether W; Wagner WH
    Arzneimittelforschung; 1976; 26(8):1543-7. PubMed ID: 795435
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Biological activity of 1,4-dihydropyridine derivatives.
    Fiszer-Maliszewska L; Wieczorek J; Mordarski M; Balicki R; Kaczmarek L; Nantka-Namirski P
    Arch Immunol Ther Exp (Warsz); 1985; 33(2):345-52. PubMed ID: 4084011
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chemotherapeutically active anthraquinones. II. Aminomethylanthraquinones.
    Winkelmann E; Raether W
    Arzneimittelforschung; 1986 Feb; 36(2):234-47. PubMed ID: 3964330
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Some new aryl-sydnones: effects on murine tumours.
    Grynberg N; Gomes R; Shinzato T; Echevarria A; Miller J
    Anticancer Res; 1992; 12(3):1025-8. PubMed ID: 1320354
    [TBL] [Abstract][Full Text] [Related]  

  • 34. (R,R)-2,2'-[1,2-ethanediylbis[imino(1-methyl-2,1-ethanediyl)]]- bis[5-nitro-1H-benz[de]isoquinoline-1,3-(2H)-dione] dimethanesulfonate (DMP 840), a novel bis-naphthalimide with potent nonselective tumoricidal activity in vitro.
    Kirshenbaum MR; Chen SF; Behrens CH; Papp LM; Stafford MM; Sun JH; Behrens DL; Fredericks JR; Polkus ST; Sipple P
    Cancer Res; 1994 Apr; 54(8):2199-206. PubMed ID: 8174127
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MX2, a morpholino anthracycline, as a new antitumor agent against drug-sensitive and multidrug-resistant human and murine tumor cells.
    Watanabe M; Komeshima N; Nakajima S; Tsuruo T
    Cancer Res; 1988 Dec; 48(23):6653-7. PubMed ID: 3180075
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synthesis and biological evaluation of some 2,4,5-trisubstituted thiazole derivatives as potential antimicrobial and anticancer agents.
    Al-Saadi MS; Faidallah HM; Rostom SA
    Arch Pharm (Weinheim); 2008 Jul; 341(7):424-34. PubMed ID: 18574850
    [TBL] [Abstract][Full Text] [Related]  

  • 37. New dioxazole derivatives: Synthesis and effects on the growth of Entamoeba histolytica and Giardia intestinalis.
    Irfan I; Sawangjaroen N; Bhat AR; Azam A
    Eur J Med Chem; 2010 Apr; 45(4):1648-53. PubMed ID: 20122767
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tyrosine kinase inhibitors. 14. Structure-activity relationships for methylamino-substituted derivatives of 4-[(3-bromophenyl)amino]-6-(methylamino)-pyrido[3,4-d]pyrimidine (PD 158780), a potent and specific inhibitor of the tyrosine kinase activity of receptors for the EGF family of growth factors.
    Rewcastle GW; Murray DK; Elliott WL; Fry DW; Howard CT; Nelson JM; Roberts BJ; Vincent PW; Showalter HD; Winters RT; Denny WA
    J Med Chem; 1998 Feb; 41(5):742-51. PubMed ID: 9513602
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Activity of SC33428, a novel bishydrazone-bridged derivative of 4-demethoxydaunorubicin, against experimental tumors in mice.
    Dawson KM
    Cancer Res; 1983 Jun; 43(6):2880-3. PubMed ID: 6573953
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Activity of a novel anthracenyl bishydrazone, 9,10-anthracenedicarboxyaldehyde Bis[(4,5-dihydro-1H-imidazol-2-yl)hydrazone] dihydrochloride, against experimental tumors in mice.
    Citarella RV; Wallace RE; Murdock KC; Angier RB; Durr FE; Forbes M
    Cancer Res; 1982 Feb; 42(2):440-4. PubMed ID: 7055799
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.